At a glance commentaryScientific background on the subjectProbiotic products consist of live bacteria that have potentially favourable health effects. A number of studies provide evidence that milk products with probiotics beneficial for digestive health and improve digestive problems. Present study investigate *Lactobacillus* species with potential activities isolated from different local made and commercially available at local market.What this study adds to the fieldThese areas of research suggest that isolates from curd samples have promising properties that are important for potential probiotics. Hence, more research is needed to exploit other potential probiotic properties. Further, *in-vivo* trials are needed to determine whether they function as probiotics in real-life situations for human health benefits.

Probiotics have been with us for as long as people have eaten fermented milk, but their association with health benefits dates only from the turn of the last century, growing awareness of the health benefits of consuming microorganisms as probiotics has encouraged consumer\'s worldwide [@bib1]. These probiotic bacteria are essential for beneficial effect on particular organism\'s health and host nutrition for healthy gastrointestinal function. Probiotics are defined as "live microorganisms when administered in adequate amounts; confer a health benefit on the host [@bib2]. This definition acknowledges a possible role for probiotics in medical practice, but does not acknowledge that probiotics (albeit rarely) can cause disease. Over the last 10 years there has been increasing public and scientific interest in the administration of these live micro-organisms to prevent or treat disease. Twenty-three publications were retrieved from PubMed for the year 1995 using the search term 'probiotic' compared with about 200 in the year 2000 and more than 600 for the first half of 2012. Much of the focus of this research has been on the use of probiotics for the prevention or treatment of gastrointestinal conditions such as inflammatory bowel disease and inflammatory bowel syndrome [@bib3], [@bib4]. More recent studies have suggested that the influence of probiotics extends well beyond the gut and may even extend to modulation of emotional states and neurological functioning [@bib5], [@bib6].

The vast majority (\>90%) of the total cells in the body are present as bacteria in the colon, reaching 10^12^ for every gram of large intestinal contents. Under natural conditions, a protective gut microflora develops and there is no need for a bacterial supplement. But the changing food habits and lifestyle force us to take processed and sterile food, which affects our access to, and colonisation, by certain type of bacteria.

The genus *Lactobacillus* belongs to the normal mucosal microbiota of humans and animals [@bib7]. This group of bacteria is important for maintaining the stability of the gastrointestinal tract, preventing intestinal infections and generally supporting intestinal health [@bib8]. Several species of *lactobacilli* have generally regarded as safe status and some can interact with intestinal epithelial cells. An important group is the *Lactobacillus* bacteria, predominantly isolated (43.48%) from locally made from households and commercially available at milk parlours. *Lactobacilli,* primarily facultative or strict anaerobes generally has fastidious growth requirement. They prefer an acidic environment by producing lactic and other acids. In general, *Lactobacilli* have not been associated with disease and have been regarded as non-pathogenic and isolates were able to tolerate the acidic condition of the environment, NaCl concentration and resistance to bile.

Lactic acid bacteria (LAB) strains are potentially promising because they generate bactericidal bioactive agents that are able to control the growth of the pathogens. Beneficial effects conferred by *Lactobacilli*, including inhibition of gram negative and positive pathogenic bacteria described by Maragkoudakis et al., 2006 [@bib9] and Charlier et al., 2008 [@bib10]. Sustaining the antimicrobial activities of probiotics will affirm their use in the development of functional foods for the betterment of the health of the consuming health [@bib11]. The isolated *Lactobacillus* isolates in the present study, exhibited very remarkable and noticeable antimicrobial activity against pathogenic bacteria, several suggestions have been proposed for inhibition of pathogenic bacteria, these might be *Lactobacillus* isolates were responsible for production of antimicrobial compounds like; bacteriocins, hydrogen peroxide and organic acids [@bib10], [@bib12], [@bib13].

Multiple mechanisms of action for the beneficial effect of probiotics have been proposed [@bib14], [@bib15], [@bib16]. The ability to adhesion of probiotic microorganism to the intestinal mucosa is considered important for many of the observed probiotic health effects. The ability to adhere to epithelial cells and mucosal surfaces has been suggested as being an important property of many bacterial strains used as probiotics. Adherence is an important prerequisite for the colonization of probiotics in the intestinal cavity, providing a competitive advantage in this ecosystem [@bib16]. Several workers have suggested that the ability of beneficial micro-organisms to aggregate and adhere aids in colonization of the gut and in the establishment of a barrier which prevents enteropathogens from establishing an infection. Factors which prevent infection include the physical presence of beneficial micro-organisms and modulation of the gut immune system by these organisms [@bib15], [@bib17], [@bib18]. Among the *Lactobacillus* isolates T2 isolate was the most dominantly evaluated the qualitatively and quantitatively the aggregation and co-aggregation capacities of collected *Lactobacillus* isolates.

The objective of this study was to isolate and characterize effective probiotic *Lactobacillus* isolates isolated from different local made from households and commercially available at local market of milk parlours. *In vitro* probiotic properties such as pH, NaCl tolerance, bile tolerance, antibiotic susceptibility profile, antimicrobial activity, auto- and co-aggregation abilities, time-kill assay and cell-surface hydrophobicity capacity of the three effectively selected probiotic isolates were investigated with selected indicator strains (pathogens) and its role in controlling the pathogen growth.

Materials and methods {#sec2}
=====================

Isolation of probiotic bacteria from different dairy products {#sec2.1}
-------------------------------------------------------------

### Collection of samples {#sec2.1.1}

This cross-sectional study was conducted at Department of Biotechnology, Gulbarga University, Kalaburagi, between September 2015 and May 2016. The different curd samples which are randomly collected from different local made from households and commercially available at local market of milk parlours. These samples were collected in clean, sterile, wide-mouthed containers, without disinfectant or detergent residue and tight-fitting leak-proof lids. Immediately after collection, the samples were transferred to the laboratory for microbiological analysis and stored aseptically in low temperature (−4 °C) refrigerator to protect from contamination and deterioration.

### Media {#sec2.1.2}

The standard media accepted by the International Dairy Federation for lactic acid bacteria differential the fermented dairy products, is deMan Rogosa Sharp (MRS) IDF 1983. The bacteria *Lactobacillus* spp. was isolated from curd samples by using modified MRS broth and MRS agar media [@bib19]. Additionally, 0.05% cysteine was added to MRS to improve the specificity of this medium for isolation of *Lactobacillus* [@bib20]. The pH of the media adjusted to 6.5 ± 0.2.

### Isolation of probiotic bacteria {#sec2.1.3}

In the present study, Bacteria were isolated from curd samples by using MRS medium. Ten gram of each collected samples were diluted with sterilized phosphate-buffered saline (PBS) and transferred to 100 ml of MRS broth at pH 6.5 MRS (deMan, Rogosa and Sharpe) medium was used for primary isolation of probiotic *Lactobacillus* bacteria by diluting the sample with normal saline solution. These solutions were added to the MRS broth and streaked on to the MRS agar plates after 6 h of incubation. The plates were aerobically incubated at 37 °C for 18--24 h. Cells were grown under a cool-white light. After incubation, white colonies that formed were selected for single-colony isolation and to isolate different strains of *Lactobacillus* species.

### Identification of *Lactobacillus* spp. {#sec2.1.4}

The isolated colony formed on the MRS agar (Hi-media pvt ltd) plates was identified by phenotypically (gram stain and biochemical tests) and genotypically (16s rRNA sequencing). The identification was performed according to Bergey\'s manual of determinative of bacteriology. The culture was kept in MRS agar slant and stored at 4 °C. For long term storage, glycerol stocks were maintained and stored at −20 °C.

Microscopic observation and colony characterization {#sec3}
===================================================

Microscopic observation {#sec3.1}
-----------------------

### Gram\'s staining {#sec3.1.1}

Prepare a smear of isolated culture on a grease free cleaned slide then fix the smear by light warming. Then slowly cover the smear using a crystal violet stain. Keep it for 1 min. Then wash off the stain with clean tap water or distilled water. Then pour a drop of Gram\'s iodine on the smear and keep it for 1 min. Then wash with water and decolourising agent absolute alcohol and again immediately wash with water. At last dry the smear and observe the smear under microscope, first with 10× objective to check staining and then under oil immersion 100×. Record the result.

Colony characterization {#sec3.2}
-----------------------

Gram positive, rod shaped bacilli cells were observed. Aerobic and facultative anaerobes, optimum temperature for growth is 35--37 °C.

### Biochemical tests {#sec3.2.1}

Suspected colonies on the primary or subculture plates resembling those of *Lactobacillus* spp. were selected for further identification by standard procedures. All the isolates were subjected to the biochemical test to identify the isolates. Identification was done on the basis of carbohydrate fermentation test, motility test, catalase and oxidase test. The performance and readings of the tests were quality controlled using the reference strains *Lactobacillus fermentum* NCDC 141, *Lactobacillus casei* NCDC297.

Characteristics of *Lactobacillus* spp. {#sec3.3}
---------------------------------------

### Determination of optimal growth at different pH {#sec3.3.1}

Determination of optimal growth and pH of *Lactobacillus spp.*, 1% (v/v) fresh over night culture (a single isolated colony was subcultured in MRS broth) of *Lactobacillus* were inoculated into MRS broth with varying pH ranging from 2 to 6.5. The pH was adjusted with concentrated acetic acid (99%) and 5 N NaOH. The inoculated broths were incubated in anaerobic condition 24 h at 37 °C. After 24 h of incubation growth of the bacteria were measured using a spectrophotometer, reading the optical density at 560 nm (OD~560~) against the uninoculated broth.

### Bile salt tolerance test {#sec3.3.2}

The ability of the strains to tolerate bile salts was determined according to the modified method described by Gilliland and colleagues [@bib21]. This bile salt tolerance test was examined for optimum growth by inoculating the various isolates separately into MRS broth tubes containing 0.5%, 1%, 1.5%, 2% and 2.5% bile salts. Bacterial growth was monitored by measuring absorbance at 600 nm after incubation for 18--24 h at 37 °C. Bile salt-free MRS was used as control for this experiment.

### NaCl tolerance test {#sec3.3.3}

For determination of NaCl tolerance, all the isolates were grown in MRS broth supplemented with different concentrations of NaCl (1--6%). The broth were inoculated with 10 μl overnight culture of the isolates and incubated anaerobically at 37 °C for 18--24 h of incubation, bacterial growth was monitored by measuring absorbance at 600 nm [@bib22] and NaCl free MRS broth used as control.

Molecular identification by 16S rRNA {#sec3.4}
------------------------------------

In the present study the determination of the 16S rRNA sequencing has been employed as a tool in arriving at identification and confirmation of bacterial strains by sequencing of 16S rRNA isolated from dairy samples. This method is fast and valid technique for molecular identification. An isolated *Lactobacillus* isolate sequence was commercially sequenced at "Chromous Biotech Pvt. Ltd, Bangalore." Crude sequence attained by sequencing the amplified for the BLASTn (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>) search at NCBI server and the homologous hits were studied. Such hits sequence across the species were recovered and issued for multiple alignments using ClustalW at EBI server. Based on the scores of multiple alignments the dendogram was produced and predicted using PHYLIP 3.6 version and studied for the evolutionary distance with other similar sequence retrieved from different species.

Antibiotic susceptibility test {#sec3.5}
------------------------------

Antibacterial susceptibility testing in the clinical laboratory is the most often performed test using the disk diffusion method [@bib23]. The method was originally standardised according to the International Organization for Standardization (ISO) and quality assurance guidelines of World Health Organization (WHO). The activated cultures were swabbed on to the Muller Hinton agar plates. In this study, various antibiotics were supplied in the form of dodeca discs (Hi Media, India) which included Ampicillin, Amoxyclav, Amikacin, Azithromycin, Cefuroxime, Cephalothin, Clindamycin, Co-trimoxazole, Chloramphenicol, Ciprofloxacin, Ceftriaxone, Erythromycin, Gentamycin, Neomycin, Novobiocin, Oxacillin, Sulfamethizole, Tetracycline and Vancomycin. The zones of inhibition were measured after incubation at 37 °C for 24 h.

Antimicrobial activity {#sec3.6}
----------------------

### Antagonistic activity against pathogens {#sec3.6.1}

Seven strains that are pathogenic to humans were used as test pathogens to investigate the antagonistic activity of the *Lactobacillus* spp. They are *Staphylococcus aureus* (MTCC 96), *Enterococcus faecalis* (MTCC439), *Klebsiella pneumonia* (MTCC 432), *Pseudomonas aeruginosa* (MTCC 7925), *E. coli* (MTCC 443), *Salmonella typhii* (MTCC734), and *Shigella* spp. (MTCC 13313) were obtained from the culture collection of Prof. C.K. lab, Department of Biotechnology, Gulbarga University, Kalaburagi.

Antimicrobial activity of selected probiotic *Lactobacillus* isolates against the test pathogenic strains were assessed using the agar spot test described by Mami et al., 2012 [@bib24], with modifications. An agar-well diffusion assay was used, aliquots of 60--80 μl of the sterile cell free supernatant were placed in 7 mm diameter wells on Muller--Hinton-agar plates previously seeded with the respective test pathogens. After 18 h of incubation at 37 °C, the diameters of the zones of growth inhibition were measured. Inhibition zones more than 20 mm, 10--20 mm and less than 10 mm were reviewed as strong, intermediate and low inhibition, respectively. The test was performed twice, each in triplicate.

### Characterization of antimicrobial substances {#sec3.6.2}

The selected probiotic *Lactobacillus* spp. (T2, T4 & T16) were assayed for production of antimicrobial substances such as bacteriocins, hydrogen peroxide and organic acids using the agar well diffusion technique described by Toure et al., 2003 [@bib25], with modifications. The bacterial strains were grown in 25 ml of MRS broth at 37 °C overnight, after which the cultures were centrifuged at 4000×*g* for 10 min at 4 °C. The supernatant of each strain was diverged into equal portion of different assays. For Bacteriocin assay, the supernatant (5 ml) treated with 1 mg/ml pronase or 1 mg/ml trypsin. For Organic acids assay, the supernatant (5 ml) was adjusted to pH 6.5 ± 0.1 using 1 N NaOH and for hydrogen peroxide assay, the supernatant (5 ml) was treated with 0.5 mg/ml catalase (Hi-media pvt ltd). Treated supernatant were filter sterilised through 0.22 μm pore-size filters (Axiva pvt ltd) and 100 μl was placed into 7 mm diameter wells, the plates were seeded with 1% (v/v) overnight culture of each indicator strain (test pathogen). The plates were kept at 4 °C for 30 min or better diffusion of the treated supernatant and then incubated for 24 h at 37 °C and diameter of inhibition zones (including 7 mm well diameter) were measured.

### Determination of minimum inhibitory concentration {#sec3.6.3}

Minimum inhibitory concentration (MIC) was determined to evaluate the phenotypic antimicrobial resistance of a strain to a certain probiotic *Lactobacillus* spp. (Cell free culture supernatant). MIC was defined as lowest *Lactobacillus* spp. concentration that resulted in no visible growth. This MIC test was determined by broth-dilution technique by following the reference standard established by ISO 2010 [@bib23]. Serial two fold dilutions (Higher and lower) of the CFCS *Lactobacillus* spp. were inoculated with an overnight culture at a final concentration of 10^7−8^ colony forming unit (cfu/ml). MIC level was determined by measuring the test pathogen\'s absorbance at 600 nm and *Lactobacillus* free broth used as control.

### Auto-aggregation of probiotic *Lactobacillus* spp. {#sec3.6.4}

Aggregation study was examined for the three selected effective probiotic *Lactobacillus* spp. from curd samples on the basis of their sedimentation characteristics. Overnight culture, 10^8^ cfu/ml each *Lactobacillus* spp. from were harvested by centrifugation at 6000×*g* for 20 min, 4 °C washed three times with Phosphate Buffer Saline (pH 7.3) and eliminated in the same buffer. Then, the mixture was vortexed and incubated at 37 °C for 4 h without agitation. The auto-aggregation percentage was asserted of three different *Lactobacillus* spp. as$$1 - \left( A_{time}/A_{initial} \right) \times 100$$where, A~time~ and A~Initial~ measured at 600 nm, represents the absorbance of the mixture at 0 h and 4 h.

### Co-aggregation of *Lactobacillus* spp. with different pathogenic cells {#sec3.6.5}

The co-aggregation analysis was performed according to slight modified method to Collado et al., 2008. The three (T2, T4 & T16) selected probiotic *Lactobacillus* spp. and seven different test pathogens were separately cultured at 37 °C for 24 h in MRS and TSB medium. Bacterial suspension (10^8^ cfu/ml) were formulated as described in the auto-aggregation in above method, equal volume of cells of the different probiotic *Lactobacillus* spp. and pathogenic strains (1:1 v/v) were mixed and incubated at 37 °C without agitation. Absorbance, A~600~ of the mixture represent above, was supervised during incubation at 4 h, percentage of co-aggregation were directed as$${Coaggregation}\left( \% \right) = \left\lbrack \left( A_{pathogen} + A_{lactobacillus} \right)/2 - A_{mix}\left( A_{pathogen} + A_{lactobacillus} \right)/2 \times 100 \right.$$where, A~pathogen~ and A~lactobacillus~ and A~mix~ represent the A~600~ of individual pathogen, *Lactobacillus* spp. and their mixture after incubation for 4 h, respectfully.

### Time-kill assay with cell free culture supernatant (CFCS) of *Lactobacillus* spp. on various pathogen {#sec3.6.6}

The time-kill assay was executed by co-culture of the each pathogenic cells and Cell free culture supernatant (CFCS) of *Lactobacillus* spp. 300 μl of pathogenic suspension, 10^8^ cfu/ml were added into 15 ml CFCS, CFCS adjusted to be pH 6.5 and MRS broth (6.5), respectively and were incubated at 37 °C. At initial and predetermined intervals, aliquots were separated, serially diluting and plating on LB agar to determine the surviving cells of individual pathogens.

### Cell surface hydrophobicity {#sec3.6.7}

Cell surface hydrophobicity was determined following to the capacity of the three different *Lactobacillus* spp. and the seven test pathogens to individually partition into xylene from PBS. The cells were washed twice with PBS and the optical density (A) at 540 nm adjusted to 0.5 ± 0.01--1.0 ml of bacterial suspension, 60 μl xylene was added and vortexed for 1 min and the optical density of the water phase was determined. Percentage hydrophobicity was calculated according to formula [@bib26].$$\left( 1 - A_{after}/A_{before} \right) \times 100$$

### Quantification of organic acid and determination of pH value {#sec3.6.8}

One percent (v/v) 24 h active culture of *Lactobacillus* isolates (T2, T4 and T16) was utilised to inoculate 10% sterilized skim milk existed from Hi-media pvt ltd Bangalore and initial pH 6.76 was determined by digital electrode pH meter. The inoculated skim milk was incubated at 37 °C for 72 h and samples were assembled in every 12 h, 24 h, 48 h and 72 h and liquids of coagulated milk were disparate by filtration. pH of the separated liquid was recorded using a digital electrode pH meter and quantification organic acid was performed through titration with 0.1 N NaOH.

### Scanning electron microscopic study {#sec3.6.9}

As it is difficult to notice small changes in cell morphologies of bacteria under the light microscope, SEM was used in the present investigation to review the changes or any rapture in cell morphology of the populations by the effect of *Lactobacillus* spp. [@bib27]. The preferred pathogen grown in TSB media with increasing antibiotic concentrations and normal pathogen. The bacterial cells from each culture were recovered by centrifugation at 6000 rpm/min and the cells were washed twice with potassium phosphate buffer (50 mM, pH 7.0). Bacterial cells were then fixed by drown in 2.5% glutaraldehyde in potassium phosphate buffer (50 mM, pH 7.0) for overnight at 4 °C. Then the specimens were washed twice with buffer and dehydrated by ethanol series (v/v) ranging from 30%, 40%, 50%, 60%, 70%, 80% and 90%--100% and stored in 100% ethanol. For SEM, the specimens were dried to critical point, coated with gold and inspected with an S-200C scanning electron microscope. Results were correlated with standard pathogenic culture and control selected pathogens.

Results {#sec4}
=======

Isolation and identification of *Lactobacillus* spp. {#sec4.1}
----------------------------------------------------

Over the period of 7 months, a total of 16 home made curd samples were collected from surrounding region to the campus and local Gulbarga city. Thirty strains were isolated, after culturing for 18--24 h, 16 (48.48%) strains were selected as forming wide and white colonies on the MRS agar plates; among the Lactic acid bacteria, the most common and predominant isolates were *Lactobacillus* spp. ([Fig. 1](#fig1){ref-type="fig"}), by noticing their colony morphology, physiological and as well as some biochemical characteristics ([Table 1](#tbl1){ref-type="table"}). Microscopically they were Gram-positive ([Fig. 2](#fig2){ref-type="fig"}), rod shaped, non-motile, catalase negative and absence of Endospore. These were subcultured on MRS with glycerol broth and stored at −20 °C. The isolated strains were named T1, T2, T3, T4, T5, T6, T7, T8, T9, T10, T11, T12, T13, T14, T15 and T16.Fig. 1Typical characteristics of the isolates grown on MRS agar medium.Fig. 1Table 1Morphological, cultural and biochemical characteristics of isolated *Lactobacillus* spp. from curd samples.Table 1Sl. NoSelected *Lactobacillus* spp.Morphological and cultural characteristicsGram\'s stainingMotility testCatalase testCarbohydrate fermentation testGlucoseSorbitolSucroseAcidGas1T11.0 mm white, rough, irregular and roundGram +ve, bacilliNon motileNegative+ve−ve−ve−ve2T2Small, 0.1--0.5 mm, rough dull and roundGram +ve, bacilliNon motileNegative−ve−ve−ve−ve3T31 mm, White, shiny smoothGram +ve, bacilliNon motileNegative−ve−ve−ve−ve4T4Small circular, white creamyGram +ve, bacilliNon motileNegative−ve−ve−ve−ve5T51.0 mm white, rough, irregular and roundGram +ve, bacilliNon motileNegative−ve−ve−ve−ve6T6Small circular, white creamyGram +ve, bacilliNon motileNegative+ve−ve−ve−ve7T7Small, 0.1--0.5 mm, rough dull and roundGram +ve, bacilliNon motileNegative+ve−ve+ve+ve8T81.0 mm white, rough, irregular and roundGram +ve, bacilliNon motileNegative+ve−ve+ve+ve9T9Small circular, white creamyGram +ve, bacilliNon motileNegative+ve−ve+ve−ve10T10Small, 0.1--0.5 mm, rough dull and roundGram +ve, bacilliNon motileNegative+ve−ve+ve+ve11T11Small circular, white creamyGram +ve, bacilliNon motileNegative+ve−ve+ve+ve12T121.0 mm white, rough, irregular and roundGram +ve, bacilliNon motileNegative+ve−ve+ve+ve13T13Small, 0.1--0.5 mm, rough dull and roundGram +ve, bacilliNon motileNegative−ve−ve+ve+ve14T14Small, irregular, smooth and circularGram +ve, bacilliNon motileNegative+ve−ve−ve+ve15T15Small circular, white creamyGram +ve, bacilliNon motileNegative+ve−ve−ve−ve16T161.0 mm white, rough, irregular and roundGram +ve, bacilliNon motileNegative−ve−ve+ve−veFig. 2Microscopic observation of Gram\'s stained *Lactobacillus* spp.Fig. 2

Characteristics of *Lactobacillus* isolates {#sec4.2}
-------------------------------------------

### Growth at different pH {#sec4.2.1}

*Lactobacillus* isolates continuance in low pH is very important for tolerating initial stress in the stomach; [Fig. 3](#fig3){ref-type="fig"} shows the results of the growth of *Lactobacillus* isolates at various pH values. The growth noted for various pH values in the range of 4.0--6.5. Representing that the bacteria adopted to grow in both acidic and neutral environment.Fig. 3Optimal growth and pH of isolated *Lactobacillus* isolates from curd samples.Fig. 3

### Tolerance to bile salt and NaCl {#sec4.2.2}

The isolated *Lactobacillus* isolates to be called as probiotics should be capable to resist inhibitory ingredient in the gastrointestinal tract like; bile salt [@bib2]. For this intent, the effect of different concentrations of bile salts in MRS broth containing 0.5--2%. The attained results suggest that all isolates of *Lactobacillus* were resistance to bile salt during the incubation period ([Fig. 4](#fig4){ref-type="fig"}). Also, *Lactobacilli* from curd samples were able to tolerate 1--6% NaCl as shown in [Fig. 5](#fig5){ref-type="fig"}.Fig. 4Bile acid tolerance of *Lactobacillus* isolates from curd samples.Fig. 4Fig. 5NaCl tolerance of *Lactobacillus* isolates from curd samples.Fig. 5

### Molecular identification of *Lactobacillus* spp. {#sec4.2.3}

The lactobacillus strain ckcs01 was identified by 16s rRNA sequencing, after the initial analysis at NCBI and RDP II ([http//:rdp.cme.msu.edu](http://rdp.cme.msu.edu){#intref0015}) website, the relevant sequences were downloaded and Phylogenetic analysis was done and tree was constructed using ClustalW software and showed the Phylogenetic relationship of the isolates ([Fig. 6](#fig6){ref-type="fig"}). In analysis of the sequence showed 99% sequence similarity with the sequence reported on *Lactobacillus* spp. and consequently isolates of ckcs01 were Phylogenetic studies indicate that the *L. fermentum.* The 16s rRNA isolate sequence is deposited in the GenBank with the accession number KX242349.Fig. 6Phylogenetic tree based on Neighbour-joining method of 16s rRNA gene sequencing.Fig. 6

### Antibiotic susceptibility test {#sec4.2.4}

The antibiotic susceptibility test was carried out for all the 16 positive potentially probiotic *Lactobacillus* spp. against the 15 antibiotics consisted different groups ([Fig. 7](#fig7){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). Isolates were shown sensitive to amoxyclav, cephalothin, co-trimoxazole, erythromycin, tetracycline, sulfamethizole, amikacin, some isolates were displayed intermediate resistance to cefuroxime, clindamycin, gentamycin, vancomycin, chloramphenicol, ciprofloxacin and prominent observation was resistance towards ampicillin, oxacillin denoted by the collect *Lactobacillus* spp.Fig. 7Antibiotic susceptibility pattern of *Lactobacillus* isolates.Fig. 7Table 2Antibiotic susceptibility test for *Lactobacillus* isolates curd samples.Table 2Sl. No.Antibiotics usedNo. of resistanceNo. of sensitiveNo. of intermediate1Ampicillin10 (87.50%)3 (18.75%)--2Amikacin5 (31.25%)11 (68.75%)--3Amoxyclav5 (31.25%)11 (68.75%)--4Cefuroxime6 (37.50%)9 (56.25%)1 (6.25%)5Cephalothin5 (31.25)%11 (68.75)%--6Chloramphenicol8 (50%)8 (50%)--7Ciprofloxacin7 (37.5%)10 (62.5%)--8Clindamycin9 (56.25%)7 (43.75%)--9Cotrimoxazole5 (31.25%)11 (68.75%)--10Erythromycin5 (31.25%)11 (68.75%)--11Gentamycin5 (31.25%)11 (68.75%)--12Oxacillin16 (100%)----13Sulfamethizole5 (31.25%)8 (50%)2 (12.5%)14Tetracycline7 (37.5%)10 (62.5%)--15Vancomycin8 (50%)5 (18.75%)3 (31.25%)

Antimicrobial activity {#sec4.3}
----------------------

### Antagonistic activity {#sec4.3.1}

The selected *Lactobacillus* isolates were noticeable to consider their antimicrobial activity by modified agar-well diffusion method. For this point, the results of antagonistic effects of the *Lactobacillus* strains were subjected against the indicator microorganisms such as *S. aureus, E. faecalis, K. pneumonia, P. aeruginosa, Escherichia coli, S. typhii* and *S.* spp. All sixteen *Lactobacillus* strains and reference strain showed antagonistic effects against all indicator microorganisms tested, but degrees of antagonism varied among the *Lactobacillus* strains. The results revealed that all the isolated *Lactobacillus* strains, exhibited the average inhibition (15--25 mm) on the growth of test pathogens, but the *Lactobacillus* strain T2, T4 and T16 was the most effective noticeable strains in inhibiting the growth of the test pathogens (28--32 mm). Overall, many of the isolated *Lactobacillus* strains showed better antagonistic activities against the test pathogen than the reference strain *L. fermentum* ([Fig. 8](#fig8){ref-type="fig"}, [Fig. 9](#fig9){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}).Fig. 8Antagonistic activity of *Lactobacillus* isolates against different test pathogens. (A) Gram-positive (B) Gram-negative.Fig. 8Fig. 9Antagonistic activity of *Lactobacillus* isolates from Curd samples.Fig. 9Table 3Antagonistic activity of *Lactobacillus* isolates against test pathogens from curd samples.Table 3Sl. No*Lactobacillus* isolatesZone of inhibition in mm (from outer edge of *Lactobacillus* colony to outer edge of clear zone)*S. aureusS. typhiE. coliE. faecalisK. pneumoniaeP. aeruginosaShigella dysentriae*1T1211918221418192T2242424352420243T3191622231818124T4242228262321215T5171424191419146T6221920211719237T7192018182015138T8162117132117199T91421142020191710T101416202020121811T111916221817142012T122214201918132013T132019192019111814T141418161920211715T152019141822221416T1630232322262524

To know, whether the isolates are bacteriostatic or bacteriocidal, confirmation test was done by modified agar overlay method were conducted; in this case swabs were taken from each clear zone of the test organism and were streaked on to nutrient agar plates for growth. Depending on the growth, the bacteriostatic and bacteriocidal activities are tabulated in that [Table 4](#tbl4){ref-type="table"}. Presence of growth of the indicator organism was elucidated as an inhibitory activity, called bacteriostatic, while no growth was expounded as bacteriocidal.Table 4Bacteriostatic and bactericidal activity of curd isolates (T2, T4 and T16).Table 4Name of the pathogensT2 isolateT4 isolateT16 isolate*S. aureus*++−*E. faecalis*++−*E. coli*−−−*P. aeruginosa*−−−*K. pneumoniae*−−−*S. typhii*−+−*Shigella* spp−++[^1]

### Characterization of inhibitory substance {#sec4.3.2}

The effective *Lactobacillus* strains (T2, T4 and T16) were considered for the characterization of inhibitory substances like bacteriocin, organic acid and hydrogen peroxide. The antimicrobial substance provided by the three *Lactobacillus* strains was characterized by agar well diffusion assay against different test pathogens. The results presented that culture supernatants of all three isolated *Lactobacillus* strains and the reference strain treated with pronase (1 mg/ml) or trypsin (1 mg/ml) did not have any inhibitory activities effects of the *Lactobacillus* spp. This indicated that inhibitory effect of *Lactobacillus* strains were due to bacteriocin production. Culture supernatants treated with catalase also did not affect the inhibitory activities of the *Lactobacillus* strains against the test pathogens. This showed that inhibition by the *Lactobacillus* strains was not due to hydrogen peroxides production. However, neutralized supernatant (pH 6.5) of all three *Lactobacillus* strains did not have any inhibitory activity effects of the *Lactobacillus* strains were due to their organic acid production. Hence, this study concludes that among three *Lactobacillus* isolates T2 isolate (ckcs01) was bacteriocin and T4, T16 isolates were responsible for organic acid production respectfully ([Fig. 10](#fig10){ref-type="fig"} and [Table 5](#tbl5){ref-type="table"}).Fig. 10Antimicrobial activity of *Lactobacillus* (CFCS) Inhibitory substances against test pathogen. (A) Bacteriocin (B) Organic acid.Fig. 10Table 5Characterization of antimicrobial substances of selected curd isolates.Table 5Sl. No.*Shigella* selected strainsT2 (in mm)T4 (in mm)T16 (in mm)Bacteriocin assayOrganic acid assayBacteriocin assayOrganic acid assayBacteriocin assayOrganic acid assay1*S. aureus*21----14--132*E. faecalis*--19--13--123*E. coli*22----18--194*P. aeruginosa*--23--17--175*K. pneumoniae*19----12--166*S. typhii*--21--18--217*Shigella* spp--17--17--22

### Minimal inhibitory concentration of cell free culture supernatant (cfcs) *Lactobacillus* spp. {#sec4.3.3}

All the selected CFCS of *Lactobacillus* isolates were used for MIC assay, the results indicated that MIC for T2 (cfcs01) isolate was 50 μl against *S. aureus, K. pneumoniae, E. coli and P. aeruginosa,* 100 μl against *E. faecalis, S. typhii* and *Shigella* spp.; T4 isolates showed MIC of 100 μl against *E. faecalis, S. typhii, S. aureus, K. pneumoniae, E. coli* and 120 μl against *P. aeruginosa* and *S.* spp. and T16 isolate showed MIC of 100 μl against *P. aeruginosa, S.* spp. *E. faecalis, S. typhii, S. aureus, K. pneumoniae* and 128 μl against *E. coli.*

### Auto- and co-aggregation assays of *Lactobacillus* spp {#sec4.3.4}

The auto-aggregation assay was examined for three effective selected *Lactobacillus* strains and the seven test pathogens on the basis of their sublimate characteristics. The results of this study revealed that, auto-aggregation expanded as a concern of time and were highest at the 24 h of incubation time period ([Table 6](#tbl6){ref-type="table"}). The percentage of auto-aggregation for all indicator strains ranged between 5% and 23%, which is 2.5 fold below the range for the *Lactobacillus,* isolates (40% and 51%) after the 24 h in the similar form. Among the *Lactobacillus* strain assay, T2 was most predominantly exhibited the highest percentage of auto-aggregation after 24 h (51%).Table 6Percentage of auto-aggregation of Probiotic selected isolates with pathogenic strains.Table 6a*Lactobacillus* StrainsAuto-aggregation (%)4 h18 h24 hT2 isolate23 ± 0.734 ± 0.251 ± 0.4T4 isolate17 ± 0.926 ± 0.840 ± 0.2T16 isolate13 ± 1.128 ± 1.248 ± 0.7**Pathogenic strains***Staphylococcus aureus*3.2 ± 1.04.2 ± 0.16.0 ± 0.9*Enterococcus faecalis*2.9 ± 1.43.6 ± 0.44.3 ± 0.8*E. coli*7.8 ± 1.214.1 ± 0.818 ± 1.2*Pseudomonas aeruginosa*4.5 ± 0.812.1 ± 1.121 ± 1.5*Klebsiella pneumoniae*6.1 ± 1.113 ± 1.319 ± 1.1*Salmonella typhi*3.1 ± 0.811 ± 0.923 ± 0.1*Shigella* spp.2.9 ± 0.410.8 ± 0.122 ± 1.0

The co-aggregation results of the three *Lactobacillus* stains tested with seven diverge test pathogens as shown in [Table 7](#tbl7){ref-type="table"}. Interrogation of all selected strains manifest their aggregation abilities with the test pathogens tested, but the percentage of the co-aggregation was strain-specific. Among the isolated strains, T2, T4 and T16 strains, revealed the notable co-aggregation with *S.* spp. as 27.3, 23.4 and 21.4% respectively, at the same state, T4 isolate exhibited the less co-aggregation abilities with *P. aerogenosa,* as well as with rest indicator strains used.Table 7Percentage of cell-surface hydrophobicity of bacterial strains.Table 6bSelected *Lactobacillus* strains% of co-aggregation with indicator strains*S. aureusE. faecalisE. coliP. aeruginosaK. pneumoniaeS. typhiiShigella* spp.T2 isolate25.6 ± 2.212.8 ± 0.819.6 ± 0.816 ± 0.818 ± 1.823 ± 0.627.3 ± 6.2T4 isolate5.4 ± 4.211.4 ± 0.67.1 ± 1.23.6 ± 0.912 ± 0.810 ± 0.421.4 ± 5.9T16 isolate11.2 ± 1.818.57 ± 0.716.8 ± 0.610.2 ± 1.214 ± 1.214 ± 0.323.4 ± 1.8

### Cell surface hydrophobicity {#sec4.3.5}

Cell-surface hydrophobicity was resoluted in order to study attainable association between this physic-chemical property and the potential to adhere to the intestinal mucus. Hydrophobic cell surface was denoted by high adherence to xylene, an apolar solvent. The hydrophobicity percentage of effective probiotic and indicator strains to xylene as shown in [Table 8](#tbl8){ref-type="table"}. The cell-surface hydrophobicity disparate with the strains in the case of selected probiotic strains, T2 isolate (73%) was most notable hydrophobic nature. The results indicated that all the other selected strains were lesser or no hydrophobic nature towards xylene from the control taken as 0%. Among the indicator strains, *S.* spp. and *E. coli* (33 & 28%) showed high hydrophobicity percentage, *P. aerogenosa and S. typhii* (20 & 19%), but *S. aureus* and *E. faecalis* (9 & 4%) formed less hydrophobicity percentages. However, no or less attachment was observed between the cell-surface hydrophobicity and the potential to adhere to the intestinal mucus.Table 8Percentage of cell-surface hydrophobicity of bacterial strains.Table 7Selected strainsCell-surface hydrophobicity (%)T273.0 ± 0.6T437 ± 0.7T1651 ± 1.2**Indicator strains***Staphylococcus aureus*9.1 ± 0.2*Enterococcus faecalis*4 ± 0.1*E. coli*28.4 ± 0.6*Pseudomonas aeruginosa*20.6 ± 1.2*Klebsiella pneumoniae*10.1 ± 0.3*Salmonella typhi*19.4 ± **0.8***Shigella* spp.33.1 ± **0.2**

### Time-kill assay with cell free culture supernatant (CFCS) of *Lactobacillus* spp. on various pathogen {#sec4.3.6}

Time-kill assay studies, exhibits the reduction in the cell counts of the different pathogens observed in the presence of concentrated CFCS of effective probiotic T2, T4 and T16 isolates ranged of 2--3 aliquots for different incubation periods (6 h, 12 h, 18 h & 24 h). The killing effect was more evident in the case of T2 isolate. In contrast, a significant decrease in the viability of indicator strains (log3-7 dilutions) was seen when CFCS of different probiotic cultures of T4 and T16 and T2 isolate were effective in killing most of pathogens as increase in the time period ([Fig. 11](#fig11){ref-type="fig"}). The outcome of the results suggests that an antibacterial substance; organic acid and bacteriocin present in the CFCS of these probiotic isolates are the responsible.Fig. 11Time kill assay of *Lactobacillus* (CFCS) isolate against test pathogen. (A) Reduction in pathogen colonies (B) Complete killing of pathogen colonies.Fig. 11

### Quantification of organic acid and determination of pH value {#sec4.3.7}

The identified *Lactobacillus* species from curd samples (T2, T4 & T16) coagulated the skim milk and produced organic acids in the sterilized skim milks which were detected by titrimetric method. The results are presented in [Table 9](#tbl9){ref-type="table"}.Table 9Quantification of organic acid and determination of pH value of selected *Lactobacillus* spp.Table 8Sources of bacteriaName of the bacteriaIncubation time (Hour)Incubation temp. (°C)Organic acid (%)pHCurdT2 (*Lactobacillus fermentum*)12370.25.4724370.285.1148370.314.9172370.334.62CurdT412370.125.3624370.225.2348370.214.7272370.304.51CurdT1612370.215.8 824370.235.3448370.294.9272370.314.45

### Scanning electron microscopic study {#sec4.3.8}

The upshots of cell morphology of test pathogen treated with cell free supernatant of *Lactobacillus* species were inspected by SEM, alteration or any rupture in the cell morphology was observed and shown in [Fig. 12](#fig12){ref-type="fig"}.Fig. 12Scanning Electron Microscopy images. (A) Control. (B) Treated with *Lactobacillus* isolate (CFCS).Fig. 12

Discussion {#sec5}
==========

The goal of the research work was to isolate, identify and characterize the potential probiotic *Lactobacillus* spp. from curd samples, locally made from households and commercially available at local market of Gulbarga city. Present study describes that, T2, T4 & T16 *Lactobacillus* isolates, considered as effective and novel probiotic bacteria to assess their anti-bacterial activity against some common human pathogens. Based on the cultural and morphological characteristics [@bib28] of each three *Lactobacillus* spp individually isolated from curd samples and these isolates were genotypically (16s rRNA) identified as *L. fermentum* and isolate were named as ckcs01. After gram staining the isolated bacteria were rod shaped, convex, rough, smooth, shiny, irregular, circular, gram positive, facultative anaerobic, non spore forming which indicate them to be the member of *Lactobacillus* spp [@bib29] ([Table 1](#tbl1){ref-type="table"}).

The significant growth of the isolates at pH 6.5 on MRS--agar plates in anaerobic conditions also confirmed their identification as *Lactobacillus* spp [@bib30]. Oxidase and catalase test of the selected isolates were exhibited same results as *Lactobacillus* spp. All the isolates were Indole, MR, VP, Citrate, Oxidase and Catalase negative, the results are similar with the decree of Elizete and Carlos [@bib31]. Among the carbohydrates used in this study, all the *Lactobacillus* isolates were able to ferment glucose, sucrose and Sorbitol. It indicates that they are able to grow in variety of habitats utilizing different type of carbohydrates. In order to be effective, probiotic bacteria must be able to survive in gastric acidic environments. In the present work, we found that incited gastric juice caused no relevant decreases in viability of *Lactobacillus* isolates. We therefore recommend these strains would likely survive in acidic environment of the stomach.

pH is an important factor which can consequentially affect bacterial growth. To be used as probiotic, organisms have to tolerate low pH of human gut. The isolated *Lactobacillus* spp. can tolerate a wide range of pH (2--8) and grow well at acidic pH (2--5) as shown in [Fig. 3](#fig3){ref-type="fig"}. NaCl is an inhibitory substance which may inhibit growth of certain types of bacteria and probiotic organisms have to withstand high salt concentration in human gut [@bib21]. The current results revealed that *Lactobacillus* spp. isolated from curd was able to tolerate 1--6% of NaCl and excellent growth was perceived at 1--5% NaCl ([Fig. 5](#fig5){ref-type="fig"}). In this present study, 0.5--2% bile salt were supplemented in the growth media, as it is signify that found in the human intestinal tract and 0.5% is the maximum concentration that is present in healthy men [@bib22]. Therefore, before selection of probiotic bacteria for human consumption it must be endurable to 0.5% bile concentration [@bib32]. *Lactobacillus* spp. isolated in this study was resistant to 0.5% bile salt. All of the isolates are able to survive and grow in 0.5% bile salt concentration ([Fig. 4](#fig4){ref-type="fig"}).

The present evaluations reveal that organic acid production was increased with the incubation time and the pH of the media decreased with the increasing acid production. From the results table, highest acidity (0.3 ± 0.2) and lowest pH (4.45 ± 0.2) was observed after 72 h incubation at 37 °C for *Lactobacillus* sp. from all the collected dairy samples. This investigation noticed that, there is a slight variation in organic acid production by *Lactobacilli* due to their regional variation ([Table 9](#tbl9){ref-type="table"}).

All bacterial products anticipated for use as feed additives must be examined to establish the susceptibility of the component strain(s) to appropriate range of antimicrobials of human or veterinary importance [@bib33]. In order to ensure the absence of transferable antibiotic resistance genes in any of the candidate probiotic strains, we assessed the antibiotic resistance profile. According to breakpoints levels established by EFSA, we found that all strains were susceptible to all antibiotics tested (except ampicillin and oxacillin), validating their safety as probiotic strains. The bacterial species used in the present study have already been recognized as well resistant to oxacillin [@bib33] ([Fig. 7](#fig7){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). Susceptibility against antibiotics is look at to be the most essential probiotic characteristic. None of the strains of *Lactobacilli* tested in this study demonstrated antimicrobial resistance when tested according to EFSA guidelines.

Antimicrobial activity is one of the most crucial selection precedents for effective and novel probiotics. Antimicrobial effects of all *Lactobacillus* isolates are sustained by producing some substances such as organic acids (lactic, acetic, propionic acids, succinic acid etc), hydrogen peroxide, low molecular weight antimicrobial substances and bacteriocins [@bib34]. Probiotics including *Lactobacillus*, *Bifidobacterium* and *Streptococcus* spp. are known to be inhibitory to the growth of a wide range of intestinal pathogens in human. In addition to the favourable effects against disease caused by an imbalance of the gut microflora, several experimental observations have revealed a potential protective effect of probiotic bacteria against the development of colon tumours [@bib35].

In the study of Osuntoki et al., 2008 [@bib28] *Lactobacillus* spp. isolated from fermented dairy products showed antibacterial activity against some clinically important pathogens such as Enterotoxigenic *E. coli* (4.2 mm), *Salmonella typhimurium* (4.3 mm) and *Listeria monocytogenes* (5.0 mm). Isolates of the present study have better antimicrobial capability than this *Lactobacillus* spp. isolates. Our isolates showed nearly similar antagonistic activity against *E. coli* and *S. typhimurium* as compared to *Lactobacillus plantarum* and *Lactobacillus salivarius* isolated by Murray et al., 2004, from a botanical probiotic. In the study by Gharaei-Fathabad and Eslamifar [@bib36], [@bib37] a strain of *Lactobacillus paraplantarum* isolated from tea leaves showed strong inhibitory activity against *S. typhii* (65 mm), *E. coli* (30 mm), *S. aureus* (56 mm), *E. faecalis* (55 mm) and *Citrobacter* spp. (60 mm). Isolates of the present study have almost similar antimicrobial capability. In our study, antagonistic activity of all selected *Lactobacillus* isolates against seven different test pathogens showed noticeable activity (as shown in [Fig. 8](#fig8){ref-type="fig"}, [Fig. 9](#fig9){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}) and achieved that the activity of these *Lactobacillus* isolates due to organic acid and low molecular weight antimicrobial substances produced from the isolates was the responsible ([Fig. 10](#fig10){ref-type="fig"}).

Aggregation between microorganisms of the same strain (auto-aggregation) or between genetically different strains (co-aggregation) is of extensive importance in several ecological niches. Aggregating bacteria may achieve an adequate mass to form biofilms or adhere to the mucosal surfaces of the host and thus utilize their functions [@bib38]. In the present study, the auto-aggregation assay was examined for three effective selected *Lactobacillus* strains and *Shigella* spp. on the basis of their sublimate characteristics. The results of this study revealed that, auto-aggregation expanded as a concern of time and were highest at the 4 h of incubation time period ([Table 6](#tbl6){ref-type="table"}, [Table 7](#tbl7){ref-type="table"}).

In conclusion of the work, *Lactobacillus* strains isolated in this study from the different dairy samples having *in vitro* properties that make them potential candidates for probiotic applications. Among the strains, *Lactobacillus* isolates from curd samples predominantly exhibited interesting probiotic properties such as excellent pH and bile tolerance, aggregations, suppression of pathogen growth under *in vitro* conditions. Moreover, all tested strains were susceptible to a number of clinically effective antibiotics. These results collectively suggest that isolates from curd samples have promising properties that are important for potential probiotics. Hence, more research is needed to exploit other potential probiotic properties of these strains. Further, *in-vivo* trials are needed to determine whether they function as probiotics in real-life situations for human health benefits.

*Lactobacillus* isolates also confirmed some probiotic properties which suggest their possible use in the medical field and most of the food industry. Indeed, a process for the incorporation of these isolates under some investigation by our research group. However, more studies are needed to complete the isolation and characterization of novel strains of *Lactobacillus* spp. and other probiotic bacteria that could be beneficial for the human health.
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[^1]: +: Bacteriostatic; −: Bacteriocidal.
